Company news
Entropy Neurodynamics Limited news in 2022
Entropy Neurodynamics Limited's news releases, calls and decks from 2022, newest first.
EX1 to Receive $0.96m in Prepayment of R&D Tax Incentive
November 25, 2022
Exopharm Received R&D Tax Incentive Refund
October 26, 2022
Study results indicate exosomes safe for clinical pursuit
September 27, 2022
FY2022 Appendix 4E and Annual Report
August 30, 2022
EX1 to receive a further $0.48m in prepaid R&D Tax Incentive
July 28, 2022
EX1 to Receive over $2.7m in Prepaid R&D Tax Incentive Claim
June 16, 2022
Business Update
May 29, 2022
Response to ASX Price Query
April 27, 2022
Appendix 4D and Half Year Report for period 31 December 2021
February 25, 2022
Response to ASX Query
February 3, 2022
Exopharm and AIRM Sign MSA
January 30, 2022